Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lung neoplasm malignant
ADR ID BADD_A05583
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.02      Respiratory tract and pleural neoplasms malignant cell type unspecified NEC
16.19.02.001      Lung neoplasm malignant
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.01      Lower respiratory tract neoplasms
22.08.01.001      Lung neoplasm malignant
Description Tumors or cancer of the LUNG. [MeSH]
MedDRA Code 10058467
MeSH ID D008175
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Ca lung | Cancer of lung | Carcinoma lung | Carcinoma of lung | Lung cancer | Lung cancer NOS | Lung cancer stage unspecified (excl metastatic tumours to lung) | Lung carcinoma | Malignant neoplasm of bronchus and lung, unspecified | Malignant neoplasm of lower lobe, bronchus or lung | Malignant neoplasm of middle lobe, bronchus or lung | Malignant neoplasm of other parts of bronchus or lung | Malignant neoplasm of trachea, bronchus, and lung | Malignant neoplasm of upper lobe, bronchus or lung | Pulmonary carcinoma | Malignant neoplasm of lower lobe | Malignant neoplasm of middle lobe | Malignant neoplasm of upper lobe | Lung neoplasm malignant | Advanced lung cancer | Lung Neoplasms | Pulmonary Neoplasms | Neoplasms, Lung | Lung Neoplasm | Neoplasm, Lung | Neoplasms, Pulmonary | Neoplasm, Pulmonary | Pulmonary Neoplasm | Lung Cancer | Cancer, Lung | Cancers, Lung | Lung Cancers | Pulmonary Cancer | Cancer, Pulmonary | Cancers, Pulmonary | Pulmonary Cancers | Cancer of the Lung | Cancer of Lung
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00701Dofetilide0.000169%
BADD_D00718Doxazosin--
BADD_D00757Eliglustat0.004312%
BADD_D00774Entecavir0.009806%
BADD_D00775Enzalutamide0.003837%
BADD_D00794Ergocalciferol0.001505%
BADD_D00800Erlotinib0.007331%
BADD_D00864Ezetimibe0.000126%
BADD_D00869Famotidine0.000045%
BADD_D00883Ferric oxyhydroxide-
BADD_D00946Fluticasone furoate--
BADD_D01008Gefitinib0.000224%
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01023Glimepiride0.000085%
BADD_D01038Goserelin0.000334%
BADD_D01086Hydrocortisone--
BADD_D01110Hydroxyurea0.000951%
BADD_D01119Ibrutinib0.001343%
BADD_D01135Iloprost0.000206%
BADD_D01136Imatinib0.001589%
BADD_D01159Insulin (human)--
BADD_D01195Irinotecan0.000492%
BADD_D01252Leflunomide0.000643%
BADD_D01260Leuprolide acetate0.007170%
BADD_D01300Lisinopril--
BADD_D01336Macitentan0.002046%
BADD_D01378Memantine0.000181%
BADD_D01418Methotrexate--
BADD_D01475Mirabegron--
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages